Literature DB >> 21382747

Cortical excitability distinguishes ALS from mimic disorders.

Steve Vucic1, Benjamin C Cheah, Con Yiannikas, Matthew C Kiernan.   

Abstract

OBJECTIVE: The diagnosis of amyotrophic lateral sclerosis (ALS) relies on stringent clinical criteria, resulting in diagnostic delay and inevitably the institution of appropriate therapy. Cortical hyperexcitability, as assessed by the novel threshold tracking transcranial magnetic stimulation (TTTMS) technique, appears as an early feature of ALS. Consequently, the present study assessed the diagnostic utility of threshold tracking TMS and developed algorithms to aid the diagnosis of ALS.
METHODS: Prospective studies were undertaken on a cohort of 156 consecutive patients with neuromuscular symptoms (104 ALS and 52 lower motor neuron syndrome, non-ALS syndrome, NALS) and 62 healthy controls.
RESULTS: Short-interval intracortical inhibition (SICI) was significantly reduced in ALS patients (2.4 ± 0.9%) compared to NALS (8.7 ± 0.8%, P<0.0001) and controls (10.6 ± 0.8%, P < 0.0001). The MEP amplitude and intracortical facilitation were increased, while the cortical silent period duration was reduced in ALS, all indicative of cortical hyperexcitability. Analysis of receiver operating characteristic curves suggested that threshold tracking TMS distinguished ALS from NALS, with averaged (area under curve 0.76, P < 0.0001) and peak SICI 3 ms (area under curve 0.73, P<0.0001) being the most robust diagnostic markers.
CONCLUSIONS: The presence of cortical hyperexcitability distinguishes ALS from mimic disorders. SIGNIFICANCE: The threshold tracking TMS techniques may prove useful as a diagnostic investigation for ALS.
Copyright © 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21382747     DOI: 10.1016/j.clinph.2010.12.062

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  33 in total

1.  Superconditioning TMS for examining upper motor neuron function in MND.

Authors:  Blair Calancie; Eufrosina Young; Mary Lou Watson; Dongliang Wang; Natalia Alexeeva
Journal:  Exp Brain Res       Date:  2019-06-07       Impact factor: 1.972

2.  Four-pulse transcranial magnetic stimulation using multiple conditioning inputs. Normative MEP responses.

Authors:  Blair Calancie; Dongliang Wang; Eufrosina Young; Natalia Alexeeva
Journal:  Exp Brain Res       Date:  2018-02-22       Impact factor: 1.972

Review 3.  Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: a Molecular and Clinical Update.

Authors:  Rocio Garcia-Santibanez; Matthew Burford; Robert C Bucelli
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-17       Impact factor: 5.081

Review 4.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.

Authors:  Gretchen M Thomsen; Genevieve Gowing; Jessica Latter; Maximus Chen; Jean-Philippe Vit; Kevin Staggenborg; Pablo Avalos; Mor Alkaslasi; Laura Ferraiuolo; Shibi Likhite; Brian K Kaspar; Clive N Svendsen
Journal:  J Neurosci       Date:  2014-11-19       Impact factor: 6.167

Review 6.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

7.  Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.

Authors:  Laura Ferraiuolo; Kathrin Meyer; Thomas W Sherwood; Jonathan Vick; Shibi Likhite; Ashley Frakes; Carlos J Miranda; Lyndsey Braun; Paul R Heath; Ricardo Pineda; Christine E Beattie; Pamela J Shaw; Candice C Askwith; Dana McTigue; Brian K Kaspar
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-29       Impact factor: 11.205

8.  Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.

Authors:  Nimeshan Geevasinga; Parvathi Menon; Garth A Nicholson; Karl Ng; James Howells; Jillian J Kril; Con Yiannikas; Matthew C Kiernan; Steve Vucic
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

Review 9.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.

Authors:  Robert Bowser; Martin R Turner; Jeremy Shefner
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

10.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.